Profile: Hercon Laboratories Corp. manufactures and develops generic transdermal medications. We offer transdermal nitroglycerin systems, a prescription drug which delivers a controlled release of nitroglycerin, for use in relief of angina pectoris. We currently work on NDA & ANDA products for pharmaceutical companies.
The company was founded in 1985, has revenues of USD 10-25 Million, has ~50 employees and is ISO certified. NASDAQ:hclc (SEC Filings)
2 Products/Services (Click for related suppliers)
|
• Nitroglycerin Transdermal Systems |
• Transdermal Patches |